Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
|Articles|February 1, 2008
New Products & Services
Cherry Hill, NJ-Vision USA's sport bifocal safety glasses have soft rubber nose and ear pads and vents between lenses and frame for enhanced comfort.
Advertisement
Bifocal glasses provide safety, magnification, comfort
For more information, visit
For more information, visit
Laser bridges allow precise laser placement
For more information, visit
Book explains female incontinence, Tx to patients
For more information, visit
Advertisement
Related to this article
Sandip M. Prasad, MD, MPhil, discusses the safety profile of mitomycin intravesical solution, including common adverse events and patient counseling during chemoablation for NMIBC.
These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.
This approval expands the label for nogapendekin alfa inbakicept to include patients with high-grade papillary-only tumors.
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
The completion of the first procedure marks the beginning of a controlled US commercial release.
Advertisement
Advertisement
Trending on Urology Times
1
Study assesses real-world outcomes with intranasal vardenafil for ED
2
Three-year data show durable responses with mitomycin intravesical solution
3
Urocross Expander System enters US commercial use for symptomatic BPH
4
Matching mCSPC treatment to the patient, not just the trial data
5